NIH-funded research R01 grant

Treating Alcohol Use Disorder in Primary Care with Semaglutide

Official title: Treating Alcohol Use Disorders in Primary Care with Semaglutide: Leveraging a Randomized Bayesian Adaptive Enrichment Design

Funded at University of Texas Hlth Sci Ctr Houston · NIH-11491479 · Data updated 2026-11-12

This grant tests whether the diabetes drug semaglutide can help adults reduce or stop drinking when used in primary care.

More Alcohol Use research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Texas Hlth Sci Ctr Houston
NIH-funded
Lab location1 site (Houston, United States)
Project startSeptember 20, 2026
Project endAugust 31, 2031
Funding year2026
Award (this year)$842,191
NIH project number1R01AA033667-01
Project IDNIH-11491479 on NIH RePORTER

Who could benefit from this research

Could help

Adults with alcohol use disorder who are receiving care in primary care settings and are interested in reducing or stopping alcohol use.

Less likely to help

Individuals with AUD who do not want to change drinking behaviors or cannot tolerate semaglutide may not benefit.

What this research studies

The study will test different doses of semaglutide versus placebo in adults with alcohol use disorder who are seen in primary care. It uses a Bayesian adaptive design to adjust which doses are most effective as the study progresses over 16 weeks. The goal is to find a practical treatment option that fits into routine primary care and aligns with patients’ real-life goals about reducing drinking rather than quitting entirely.

Why it matters

Potential benefit: If successful, patients could have a newer, easier-to-access option to reduce or stop alcohol use within regular medical care.

How similar studies have gone: Previous studies suggest GLP-1 receptor agonists may help reduce alcohol consumption, but this approach in primary care with adaptive dosing is novel.

Where this research is happening

  • University of Texas Hlth Sci Ctr Houston
    Houston, United States
    Active

Researchers

  • Principal investigator: Northrup, Thomas Francis — University of Texas Hlth Sci Ctr Houston
  • Study coordinator: Northrup, Thomas Francis

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.